These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8582449)

  • 1. Lack of plasma lipid peroxidation during LDL-apheresis by heparin-induced extracorporeal LDL-precipitation.
    Wieland E; Schettler V; Creutzfeldt C; Kickbusch H; Schuff-Werner P
    Eur J Clin Invest; 1995 Nov; 25(11):838-42. PubMed ID: 8582449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in plasma lipid and apolipoprotein levels between heparin-induced extracorporeal low-density lipoprotein precipitation (HELP) treatments.
    Lane DM; Alaupovic P; Knight-Gibson C; Dudley VS; Laughlin LO
    Am J Cardiol; 1995 Jun; 75(16):1124-9. PubMed ID: 7762498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low density lipoprotein immunoapheresis does not increase plasma lipid peroxidation products in vivo.
    Kostner K; Banyai S; Jansen M; Khoschsorur G; Hörl WH; Maurer G; Winklhofer-Roob B; Derfler K
    Clin Chim Acta; 1999 Oct; 288(1-2):21-30. PubMed ID: 10529454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of HELP-LDL-apheresis on outcomes in patients with advanced coronary atherosclerosis and severe hypercholesterolemia.
    Park JW; Merz M; Braun P
    Atherosclerosis; 1998 Aug; 139(2):401-9. PubMed ID: 9712348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct effects of LDL apheresis by hemoperfusion (DALI) and heparin-induced extracorporeal precipitation (HELP) on leukocyte respiratory burst activity of patients with familial hypercholesterolemia.
    Kopprasch S; Julius U; Gromeier S; Kühne H; Graessler J
    J Clin Apher; 2000; 15(4):249-55. PubMed ID: 11124693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [H.E.L.P. apheresis and oxidative stress].
    Pulawski E; Mellwig KP; Horstkotte D
    Z Kardiol; 2003; 92(Suppl 3):III38-41. PubMed ID: 14663600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical long-term results of H.E.L.P.-apheresis].
    Schuff-Werner P
    Z Kardiol; 2003; 92(Suppl 3):III28-9. PubMed ID: 14663598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma lipids are not oxidized during hemodialysis.
    Schettler V; Wieland E; Verwiebe R; Schuff-Werner P; Scheler F; Oellerich M
    Nephron; 1994; 67(1):42-7. PubMed ID: 8052366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Heparin-induced extracorporeal LDL precipitation (H.E.L.P.)].
    Horstkotte D; Mellwig KP
    Z Kardiol; 2003; 92(Suppl 3):III1-5. PubMed ID: 14663596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement activation and depletion during LDL-apheresis by heparin-induced extracorporeal LDL-precipitation (HELP).
    Würzner R; Schuff-Werner P; Franzke A; Nitze R; Oppermann M; Armstrong VW; Eisenhauer T; Seidel D; Götze O
    Eur J Clin Invest; 1991 Jun; 21(3):288-94. PubMed ID: 1909632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prevention of early graft occlusion after coronary bypass grafting by post-operative reduction of plasma fibrinogen by H.E.L.P. apheresis. First evaluation of 12 patients treated during our study (44 bypasses)].
    Blessing F; Jaeger BR; Oberhoffer M; Reichart B; Seidel D
    Z Kardiol; 2003; 92(Suppl 3):III42-7. PubMed ID: 14663601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of heparin-induced extracorporeal low-density lipoprotein precipitation (HELP) apheresis on hepatitis C plasma virus load.
    Schettler V; Monazahian M; Wieland E; Thomssen R; Müller GA
    Ther Apher; 2001 Oct; 5(5):384-6. PubMed ID: 11778924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review: the oxidant/antioxidant balance during regular low density lipoprotein apheresis.
    Schettler V; Methe H; Staschinsky D; Schuff-Werner P; Müller GA; Wieland E
    Ther Apher; 1999 Aug; 3(3):219-26. PubMed ID: 10427619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective removal of plasma low density lipoprotein with the HELP system: biweekly versus weekly therapy.
    Lane DM; McConathy WJ; Laughlin LO; Comp PC; von Albertini B; Bricker LA; Kozlovskis P; Lees RS; Dorrier C
    Atherosclerosis; 1995 Apr; 114(2):203-11. PubMed ID: 7605389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Myocardial perfusion under H.E.L.P. -apheresis. Objectification by PET].
    Mellwig KP; Baller D; Schmidt HK; V Buuren F; Wielepp JP; Burchert W; Horstkotte D
    Z Kardiol; 2003; 92(Suppl 3):III30-7. PubMed ID: 14663599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LDL-apheresis with the HELP system: a 16-month study in severe hypercholesterolemic patients with ischemic heart disease.
    Baggio G; Previato L; Corti C; Bilato C; Belloni M; Ongaro G; Crepaldi G
    Beitr Infusionsther; 1988; 23():146-51. PubMed ID: 2484770
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of two low-density lipoprotein apheresis systems in patients with homozygous familial hypercholesterolemia.
    Drouin-Chartier JP; Tremblay AJ; Bergeron J; Pelletier M; Laflamme N; Lamarche B; Couture P
    J Clin Apher; 2016 Aug; 31(4):359-67. PubMed ID: 26011648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Highly effective reduction of C-reactive protein in patients with coronary heart disease by extracorporeal low density lipoprotein apheresis.
    Wieland E; Schettler V; Armstrong VW
    Atherosclerosis; 2002 May; 162(1):187-91. PubMed ID: 11947913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Heparin-induced extracorporeal LDL precipitation (HELP): a new therapeutic intervention in cerebrovascular diseases and peripheral arterial occlusive disease].
    Walzl B; Walzl M; Lechner P; Lechner H; Cesnik H
    Wien Med Wochenschr; 1993; 143(22):563-70. PubMed ID: 8154130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased susceptibility of low-density lipoproteins to in-vitro oxidation after dextran-sulfate LDL-apheresis treatment.
    Leitinger N; Pirich C; Blazek I; Endler G; Sinzinger H
    Atherosclerosis; 1996 Oct; 126(2):305-12. PubMed ID: 8902156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.